アジア太平洋の凝固：2030年市場予測-地域別分析-適応疾患別、タイプ別、提供品目別、技術別、エンドユーザー別

アジア太平洋の凝固市場は2022年に8億8,952万米ドルと評価され、2030年には16億7,249万米ドルに達すると予測され、2022年から2030年までのCAGRは8.2%で成長すると推定されます。

主要市場企業による有機的・無機的戦略の成長がアジア太平洋の凝固市場を後押し

生活習慣の変化や高齢者人口の増加が、血液疾患の有病率を高める主な要因の1つです。そのため、早期診断と治療に対する需要が高まっています。主要企業は、患者集団の生活の質を向上させるために、有機的・無機的なさまざまな戦略を通じてさまざまな取り組みを行っています。

• 2020年7月、シスメックス株式会社は自動血液凝固分析装置CN-6500/CN-3500を日本で発売しました。この分析装置は、血液凝固・血小板凝集パラメータ、血栓症・止血パラメータを測定します。
• 2021年10月、トリビトロン・ヘルスケアはインドのダイアゴン社製凝固分析装置の新ラインを発売しました。
• 2021年6月、トリビトロン・ヘルスケアは糖尿病、ヘモグロビン変動、サラセミアのモニタリングに役立つNANO H5とNANO H110を発表しました。
• 2021年2月、シーメンス・ヘルティニアーズとシスメックス・コーポレーションは、全世界における止血製品の供給、流通、販売、サービスに関する契約を更新しました。この契約には複数年の延長も含まれています。さらに、シーメンス・ヘルスイニアーズ社は、シスメックス社の自動血液凝固分析装置CN-3000およびCN-6000の販売にも合意しました。
• 2022年7月、堀場メディカルは最新の止血分析装置であるYumizen G800とG1550、および一般的な血液凝固検査に便利な即使用可能な試薬のラインナップを発売しました。この製品ラインアップの拡充により、堀場メディカルは、あらゆる規模や要件の検査室向けに、包括的な止血システムと高度な試薬のセレクションを提供できるようになった。

このように、主要市場企業による有機的・無機的なさまざまな戦略の採用は、予測期間中に凝固市場の成長機会をもたらすと期待されています。

アジア太平洋の凝固市場概要

アジア太平洋の凝固市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋に区分されます。この地域における市場拡大の要因としては、高齢者人口の増加、心血管疾患の増加、出血性疾患の有病率の増加、流通網の開拓、凝固分析装置の進歩などが挙げられます。

National Center for Biotechnology Information（NCBI）に掲載された論文「Cardiovascular Health and Diseases in China 2022」によると、中国の農村部と都市部では、心血管疾患（CVD）が全死亡原因の47%と44%を占めています。2020年には、中国では3億3,000万人近くの患者がCVDに苦しむと予測されています。Lancet誌に掲載された調査によると、中国ではCVDが毎年400万人の死亡原因となっています。CVD患者は体内の凝固因子のレベルが高いです。したがって、CVDの有病率の上昇が中国の凝固市場の成長を後押ししています。

アジア太平洋の凝固市場の収益と2030年までの予測（金額）

アジア太平洋の凝固市場セグメンテーション

アジア太平洋の凝固市場は、適応疾患、タイプ、製品、技術、エンドユーザー、国によって区分されます。

疾患適応症に基づき、アジア太平洋の凝固市場はビタミンK欠乏症、肝疾患、播種性血管内凝固・肺塞栓症、循環性抗凝固薬の開発、血友病、フォンウィルブランド病、その他に区分されます。2022年のアジア太平洋の凝固市場シェアは、肝疾患分野が最大でした。

タイプ別に見ると、アジア太平洋の凝固市場は臨床検査用分析装置とポイントオブケア検査用分析装置に二分されます。2022年のアジア太平洋の凝固市場シェアは、臨床検査分析装置分野が大きいです。臨床検査分析装置セグメントはさらに、コントロール＆キャリブレーター、アッセイ＆試薬、機器／システム、凝固因子、その他に細分化されます。

提供サービスの観点から、アジア太平洋の凝固市場は診断と治療に二分されます。2022年のアジア太平洋の凝固市場シェアは、診断部門が大きいです。診断セグメントはさらに、プロトロンビン時間検査、フィブリノゲン検査、活性化凝固時間検査、活性化部分トロンボプラスチン時間検査、dダイマー検査、血小板機能検査、その他の活動に細分化されます。治療分野はさらに、抗線溶薬、避妊薬、デスモプレシン＆免疫抑制薬、ビタミンkサプリメント、血液希釈薬、トロンビン阻害薬または血栓溶解薬、補充療法、カテーテル補助血栓除去、その他に細分化されます。

技術別に見ると、アジア太平洋の凝固市場は光学技術、機械技術、電気化学技術、その他に区分されます。2022年のアジア太平洋の凝固市場シェアは、光学技術分野が最大でした。

エンドユーザー別では、アジア太平洋の凝固市場は臨床検査室、病院、その他に区分されます。2022年のアジア太平洋の凝固市場シェアは病院セグメントが最大でした。

国別に見ると、アジア太平洋の凝固市場は中国、日本、インド、韓国、オーストラリア、その他アジア太平洋に分類されます。2022年のアジア太平洋の凝固市場は中国が支配的でした。

F.Hoffmann-La Roche Ltd.、Genrui Biotech Co.Ltd.、Horiba Ltd.、ImproGen Diagnostik Kimya San &Tic Ltd.Sti.、Siemens Healthineers AG、Sysmex Corp.、Transasia Bio-Medicals Ltd.などがアジア太平洋の凝固市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

• 主要な洞察

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 アジア太平洋の凝固市場- 主要産業力学

• 主な市場促進要因
  • 血液疾患の有病率の増加
  • 心血管疾患の有病率の上昇
• 市場抑制要因
  • 凝固分析装置に関連する高コスト
• 市場機会
  • 主要市場企業による有機的・無機的戦略の成長
• 今後の動向
  • ポイントオブケア（POC）凝固分析装置の発展
• 影響分析

第5章 凝固市場：アジア太平洋市場分析

• アジア太平洋の凝固市場売上高、2022年～2030年

第6章 アジア太平洋の凝固市場-2030年までの収益と予測：適応疾患別

• アジア太平洋の凝固市場：2022年および2030年の疾患別売上高シェア（%）
• ビタミンK欠乏症
• 肝疾患
• 播種性血管内凝固症候群および肺塞栓症
• 循環型抗凝固薬の開発
• 血友病
• フォンウィルブランド病
• その他

第7章 アジア太平洋の凝固市場：タイプ別収益と2030年までの予測

• アジア太平洋の凝固市場2022年・2030年タイプ別売上高シェア（%）
• 臨床検査分析装置
• ポイントオブケア検査分析装置

第8章 アジア太平洋の凝固市場：収益と2030年までの予測：製品別

• アジア太平洋の凝固市場：2022年および2030年のオファリング別売上高シェア（%）
• 診断
• 治療

第9章 アジア太平洋の凝固市場-2030年に至る収益と予測-技術別

• アジア太平洋の凝固市場：2022年および2030年の技術別売上高シェア（%）
• 光学技術
• 機械技術
• 電気化学技術
• その他

第10章 アジア太平洋の凝固市場：エンドユーザー別収益と2030年までの予測

• アジア太平洋の凝固市場：2022年および2030年のエンドユーザー別売上高シェア（%）
• 臨床検査室
• 病院
• その他

第11章 アジア太平洋の凝固市場：国別分析

• 中国
• 日本
• インド
• オーストラリア
• 韓国
• その他アジア太平洋

第12章 凝固市場-業界情勢

• 凝固市場の成長戦略
• 無機的成長戦略
  • 無機的成長戦略
• 有機的成長戦略

第13章 企業プロファイル

• Siemens Healthineers AG
• ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
• Sysmex Corp
• F. Hoffmann-La Roche Ltd
• Genrui Biotech Co., Ltd.
• Transasia Bio-Medicals Ltd
• Horiba Ltd.

第14章 付録

List Of Tables

• Table 1. Asia Pacific Coagulation Market Segmentation
• Table 2. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
• Table 3. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
• Table 4. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
• Table 5. Optical Technologies and Their Applications
• Table 6. Mechanical Technologies and Their Applications
• Table 7. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
• Table 8. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
• Table 9. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
• Table 10. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
• Table 11. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
• Table 12. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
• Table 13. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
• Table 14. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
• Table 15. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
• Table 16. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
• Table 17. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
• Table 18. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
• Table 19. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
• Table 20. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
• Table 21. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
• Table 22. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
• Table 23. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
• Table 24. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
• Table 25. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
• Table 26. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
• Table 27. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
• Table 28. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
• Table 29. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
• Table 30. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
• Table 31. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
• Table 32. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
• Table 33. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
• Table 34. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
• Table 35. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
• Table 36. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
• Table 37. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
• Table 38. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
• Table 39. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
• Table 40. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
• Table 41. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
• Table 42. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
• Table 43. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
• Table 44. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
• Table 45. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
• Table 46. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
• Table 47. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
• Table 48. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
• Table 49. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
• Table 50. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
• Table 51. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
• Table 52. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
• Table 53. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
• Table 54. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
• Table 55. Recent Inorganic Growth Strategies in the Coagulation Market
• Table 56. Recent Organic Growth Strategies in the Coagulation Market
• Table 57. Glossary of Terms, Coagulation Market

List Of Figures

• Figure 1. Asia Pacific Coagulation Market Segmentation, By Country
• Figure 2. Asia Pacific Coagulation Market - Key Industry Dynamics
• Figure 3. Impact Analysis of Drivers and Restraints
• Figure 4. Asia Pacific Coagulation Market Revenue (US$ million), 2020 - 2030
• Figure 5. Asia Pacific Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
• Figure 6. Vitamin K Deficiency: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 7. Liver Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 9. Development of Circulating Anticoagulant: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 10. Hemophilia: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 11. Von Willebrand's Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 12. Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 13. Asia Pacific Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
• Figure 14. Clinical Laboratory Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 15. Point-of-Care Testing Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 16. Asia Pacific Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
• Figure 17. Diagnosis: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 18. Treatment: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 19. Asia Pacific Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
• Figure 20. Optical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 21. Mechanical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 22. Electrochemical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 23. Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 24. Asia Pacific Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
• Figure 25. Clinical Laboratories: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 26. Hospitals: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 27. Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 28. Coagulation Market, By Geography, 2022 (US$ Million)
• Figure 29. Asia Pacific Coagulation Market, By Key Countries, 2022 and 2030 (%)
• Figure 30. China Coagulation Market Revenue and Forecast to 2030 (US$ million)
• Figure 31. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
• Figure 32. India Coagulation Market Revenue and Forecast to 2030 (US$ million)
• Figure 33. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
• Figure 34. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
• Figure 35. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
• Figure 36. Growth Strategies in the Coagulation Market

The Asia Pacific coagulation market was valued at US$ 889.52 million in 2022 and is expected to reach US$ 1,672.49 million by 2030; it is estimated to grow at a CAGR of 8.2% from 2022 to 2030.

Growing Organic and Inorganic Strategies by Key Market Players Fuel Asia Pacific Coagulation Market

Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.

• In July 2020, Sysmex Corporation launched the Automated Blood Coagulation Analyzers CN-6500/CN-3500 in Japan. The analyzer measures blood coagulation and platelet aggregation parameters, as well as thrombosis and hemostasis parameters.
• In October 2021, Trivitron Healthcare launched a new line of coagulation analyzer products manufactured by Diagon Ltd in India.
• In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.
• In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex's automated blood coagulation analyzer, such as the CN-3000 and CN-6000.
• In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation Offerings. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.

Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period.

Asia Pacific Coagulation Market Overview

The Asia Pacific coagulation market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The factors contributing to the market progress in this region include the rising geriatric population, increasing incidences of cardiovascular diseases, growing prevalence of bleeding disorders, development of distribution networks, and advancements in coagulation analyzers.

According to an article published in the National Center for Biotechnology Information (NCBI), "Cardiovascular Health and Diseases in China 2022," cardiovascular diseases (CVD) are the cause of ~47% and ~44% of all deaths in rural and urban regions in China, respectively. In 2020, nearly 330 million patients are predicted to suffer from CVD in China. According to a research study published in The Lancet, CVDs cause ~4 million deaths each year in China. CVD patients have elevated levels of coagulation factors in their bodies. Hence, an upsurge in the prevalence of CVDs is fueling the growth of the coagulation market in China.

Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Coagulation Market Segmentation

The Asia Pacific coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.

Based on disease indication, the Asia Pacific coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest Asia Pacific coagulation market share in 2022.

Based on type, the Asia Pacific coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger Asia Pacific coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the Asia Pacific coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger Asia Pacific coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the Asia Pacific coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest Asia Pacific coagulation market share in 2022.

By end user, the Asia Pacific coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest Asia Pacific coagulation market share in 2022.

Based on country, the Asia Pacific coagulation market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific coagulation market in 2022.

F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San & Tic Ltd.Sti., Siemens Healthineers AG; Sysmex Corp; and Transasia Bio-Medicals Ltd are some of the leading companies operating in the Asia Pacific coagulation market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific Coagulation Market - Key Industry Dynamics

• 4.1 Key Market Drivers:
  • 4.1.1 Increasing Prevalence of Blood Disorders
  • 4.1.2 Rising Prevalence of Cardiovascular Diseases
• 4.2 Market Restraints
  • 4.2.1 High Costs Associated with Coagulation Analyzers
• 4.3 Market Opportunities
  • 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
• 4.4 Future Trends
  • 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
• 4.5 Impact Analysis

5. Coagulation Market - Asia Pacific Market Analysis

• 5.1 Asia Pacific Coagulation Market Revenue (US$ million), 2022 - 2030

6. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

• 6.1 Overview
• 6.2 Asia Pacific Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
• 6.3 Vitamin K Deficiency
  • 6.3.1 Overview
  • 6.3.2 Vitamin K Deficiency: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 Liver Disease
  • 6.4.1 Overview
  • 6.4.2 Liver Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
  • 6.5.1 Overview
  • 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.6 Development of Circulating Anticoagulant
  • 6.6.1 Overview
  • 6.6.2 Development of Circulating Anticoagulant: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.7 Hemophilia
  • 6.7.1 Overview
  • 6.7.2 Hemophilia: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.8 Von Willebrand's Disease
  • 6.8.1 Overview
  • 6.8.2 Von Willebrand's Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.9 Others
  • 6.9.1 Overview
  • 6.9.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Type

• 7.1 Overview
• 7.2 Asia Pacific Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
• 7.3 Clinical Laboratory Analyzers
  • 7.3.1 Overview
  • 7.3.2 Clinical Laboratory Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.2.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzers
• 7.4 Point-of-Care Testing Analyzers
  • 7.4.1 Overview
  • 7.4.2 Point-of-Care Testing Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Offering

• 8.1 Overview
• 8.2 Asia Pacific Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
• 8.3 Diagnosis
  • 8.3.1 Overview
  • 8.3.2 Diagnosis: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.2.1 Asia Pacific Coagulation Market, by Diagnosis
• 8.4 Treatment
  • 8.4.1 Overview
  • 8.4.2 Treatment: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.4.2.1 Asia Pacific Coagulation Market, by Treatment

9. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Technology

• 9.1 Overview
• 9.2 Asia Pacific Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
• 9.3 Optical Technology
  • 9.3.1 Overview
  • 9.3.2 Optical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Mechanical Technology
  • 9.4.1 Overview
  • 9.4.2 Mechanical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Electrochemical Technology
  • 9.5.1 Overview
  • 9.5.2 Electrochemical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by End User

• 10.1 Overview
• 10.2 Asia Pacific Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
• 10.3 Clinical Laboratories
  • 10.3.1 Overview
  • 10.3.2 Clinical Laboratories: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 10.4 Hospitals
  • 10.4.1 Overview
  • 10.4.2 Hospitals: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 10.5 Others
  • 10.5.1 Overview
  • 10.5.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Coagulation Market - Country Analysis

• 11.1 Asia Pacific Coagulation Market, Revenue and Forecast to 2030
  • 11.1.1 Asia Pacific Coagulation Market by Country
    • 11.1.1.1 China
      • 11.1.1.1.1 China Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.1.2 China Coagulation Market, by Disease Indication
      • 11.1.1.1.3 China Coagulation Market, by Type
      • 11.1.1.1.3.1 China Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.1.4 China Coagulation Market, by Offering
      • 11.1.1.1.4.1 China Coagulation Market, by Diagnosis
      • 11.1.1.1.4.2 China Coagulation Market, by Treatment
      • 11.1.1.1.5 China Coagulation Market, by Technology
      • 11.1.1.1.6 China Coagulation Market, by End User
    • 11.1.1.2 Japan
      • 11.1.1.2.1 Overview
      • 11.1.1.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.2.3 Japan Coagulation Market, by Disease Indication
      • 11.1.1.2.4 Japan Coagulation Market, by Type
      • 11.1.1.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.2.5 Japan Coagulation Market, by Offering
      • 11.1.1.2.5.1 Japan Coagulation Market, by Diagnosis
      • 11.1.1.2.5.2 Japan Coagulation Market, by Treatment
      • 11.1.1.2.6 Japan Coagulation Market, by Technology
      • 11.1.1.2.7 Japan Coagulation Market, by End User
    • 11.1.1.3 India
      • 11.1.1.3.1 Overview
      • 11.1.1.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.3.3 India Coagulation Market, by Disease Indication
      • 11.1.1.3.4 India Coagulation Market, by Type
      • 11.1.1.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.3.5 India Coagulation Market, by Offering
      • 11.1.1.3.5.1 India Coagulation Market, by Diagnosis
      • 11.1.1.3.5.2 India Coagulation Market, by Treatment
      • 11.1.1.3.6 India Coagulation Market, by Technology
      • 11.1.1.3.7 India Coagulation Market, by End User
    • 11.1.1.4 Australia
      • 11.1.1.4.1 Overview
      • 11.1.1.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.4.3 Australia Coagulation Market, by Disease Indication
      • 11.1.1.4.4 Australia Coagulation Market, by Type
      • 11.1.1.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.4.5 Australia Coagulation Market, by Offering
      • 11.1.1.4.5.1 Australia Coagulation Market, by Diagnosis
      • 11.1.1.4.5.2 Australia Coagulation Market, by Treatment
      • 11.1.1.4.6 Australia Coagulation Market, by Technology
      • 11.1.1.4.7 Australia Coagulation Market, by End User
    • 11.1.1.5 South Korea
      • 11.1.1.5.1 Overview
      • 11.1.1.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.5.3 South Korea Coagulation Market, by Disease Indication
      • 11.1.1.5.4 South Korea Coagulation Market, by Type
      • 11.1.1.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.5.5 South Korea Coagulation Market, by Offering
      • 11.1.1.5.5.1 South Korea Coagulation Market, by Diagnosis
      • 11.1.1.5.5.2 South Korea Coagulation Market, by Treatment
      • 11.1.1.5.6 South Korea Coagulation Market, by Technology
      • 11.1.1.5.7 South Korea Coagulation Market, by End User
    • 11.1.1.6 Rest of Asia Pacific
      • 11.1.1.6.1 Overview
      • 11.1.1.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication
      • 11.1.1.6.4 Rest of Asia Pacific Coagulation Market, by Type
      • 11.1.1.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.6.5 Rest of Asia Pacific Coagulation Market, by Offering
      • 11.1.1.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis
      • 11.1.1.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment
      • 11.1.1.6.6 Rest of Asia Pacific Coagulation Market, by Technology
      • 11.1.1.6.7 Rest of Asia Pacific Coagulation Market, by End User

12. Coagulation Market-Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies in the Coagulation Market
• 12.3 Inorganic Growth Strategies
  • 12.3.1 Overview
• 12.4 Organic Growth Strategies
  • 12.4.1 Overview

13. Company Profiles

• 13.1 Siemens Healthineers AG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Sysmex Corp
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 F. Hoffmann-La Roche Ltd
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 Genrui Biotech Co., Ltd.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 Transasia Bio-Medicals Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 Horiba Ltd.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

• 14.1 About Us
• 14.2 Glossary of Terms